Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

P. aeruginosa colonization at ICU admission as a risk factor for developing P. aeruginosa ICU pneumonia.

Paling FP, Wolkewitz M, Depuydt P, de Bus L, Sifakis F, Bonten MJM, Kluytmans JAJW.

Antimicrob Resist Infect Control. 2017 Apr 20;6:38. doi: 10.1186/s13756-017-0197-9. eCollection 2017.

2.

In vitro evaluation of the susceptibility of Acinetobacter baumannii isolates to antiseptics and disinfectants: comparison between clinical and environmental isolates.

Lanjri S, Uwingabiye J, Frikh M, Abdellatifi L, Kasouati J, Maleb A, Bait A, Lemnouer A, Elouennass M.

Antimicrob Resist Infect Control. 2017 Apr 11;6:36. doi: 10.1186/s13756-017-0195-y. eCollection 2017.

3.

Research on the treatment of Pseudomonas aeruginosa pneumonia in children by macrolide antibiotics.

Huang XQ, Deng L, Lu G, He CH, Wu PQ, Xie ZW, Ashraf MA.

Open Med (Wars). 2015 Dec 17;10(1):479-482. doi: 10.1515/med-2015-0082. eCollection 2015.

4.

Hepcidin-mediated iron sequestration protects against bacterial dissemination during pneumonia.

Michels KR, Zhang Z, Bettina AM, Cagnina RE, Stefanova D, Burdick MD, Vaulont S, Nemeth E, Ganz T, Mehrad B.

JCI Insight. 2017 Mar 23;2(6):e92002. doi: 10.1172/jci.insight.92002.

5.

Innovative Self-Cleaning and Biocompatible Polyester Textiles Nano-Decorated with Fe-N-Doped Titanium Dioxide.

Nica IC, Stan MS, Dinischiotu A, Popa M, Chifiriuc MC, Lazar V, Pircalabioru GG, Bezirtzoglou E, Iordache OG, Varzaru E, Dumitrescu I, Feder M, Vasiliu F, Mercioniu I, Diamandescu L.

Nanomaterials (Basel). 2016 Nov 15;6(11). pii: E214. doi: 10.3390/nano6110214.

6.

The Cytokine Response to Lipopolysaccharide Does Not Predict the Host Response to Infection.

Fensterheim BA, Guo Y, Sherwood ER, Bohannon JK.

J Immunol. 2017 Apr 15;198(8):3264-3273. doi: 10.4049/jimmunol.1602106. Epub 2017 Mar 8.

PMID:
28275139
7.

Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.

Bouglé A, Foucrier A, Dupont H, Montravers P, Ouattara A, Kalfon P, Squara P, Simon T, Amour J; iDIAPASON study group..

Trials. 2017 Jan 23;18(1):37. doi: 10.1186/s13063-017-1780-3.

8.

Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Alp S, Akova M.

Mediterr J Hematol Infect Dis. 2017 Jan 1;9(1):e2017002. doi: 10.4084/MJHID.2017.002. eCollection 2017. Review.

9.

Modeling Acinetobacter baumannii wound infections: The critical role of iron.

Fleming ID, Krezalek MA, Belogortseva N, Zaborin A, Defazio J, Chandrasekar L, Actis LA, Zaborina O, Alverdy JC.

J Trauma Acute Care Surg. 2017 Mar;82(3):557-565. doi: 10.1097/TA.0000000000001338.

PMID:
28030490
10.

Do Bacterial "Virulence Factors" Always Increase Virulence? A Meta-Analysis of Pyoverdine Production in Pseudomonas aeruginosa As a Test Case.

Granato ET, Harrison F, Kümmerli R, Ross-Gillespie A.

Front Microbiol. 2016 Dec 12;7:1952. doi: 10.3389/fmicb.2016.01952. eCollection 2016.

11.

How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.

Hughes JS, Hurford A, Finley RL, Patrick DM, Wu J, Morris AM.

BMJ Open. 2016 Dec 16;6(12):e012040. doi: 10.1136/bmjopen-2016-012040.

12.

Prolonged outbreak of clonal MDR Pseudomonas aeruginosa on an intensive care unit: contaminated sinks and contamination of ultra-filtrate bags as possible route of transmission?

Salm F, Deja M, Gastmeier P, Kola A, Hansen S, Behnke M, Gruhl D, Leistner R.

Antimicrob Resist Infect Control. 2016 Dec 6;5:53. eCollection 2016.

13.

Penicillin-Binding Protein 3 Is Essential for Growth of Pseudomonas aeruginosa.

Chen W, Zhang YM, Davies C.

Antimicrob Agents Chemother. 2016 Dec 27;61(1). pii: e01651-16. doi: 10.1128/AAC.01651-16. Print 2017 Jan.

PMID:
27821444
14.

Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements.

Miller SE, Bell CS, McClain MS, Cover TL, Giorgio TD.

PLoS One. 2016 Sep 22;11(9):e0163167. doi: 10.1371/journal.pone.0163167. eCollection 2016.

15.

Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa.

Sonmezer MC, Ertem G, Erdinc FS, Kaya Kilic E, Tulek N, Adiloglu A, Hatipoglu C.

Can J Infect Dis Med Microbiol. 2016;2016:1321487. doi: 10.1155/2016/1321487. Epub 2016 Aug 30.

16.

Decreased Pseudomonas aeruginosa biofilm formation on nanomodified endotracheal tubes: a dynamic lung model.

Machado MC, Webster TJ.

Int J Nanomedicine. 2016 Aug 9;11:3825-31. doi: 10.2147/IJN.S108253. eCollection 2016.

17.

Risk factors associated with postcraniotomy meningitis: A retrospective study.

Chen CH, Chang CY, Lin LJ, Chen WL, Chang YJ, Wang SH, Cheng CY, Yen HC.

Medicine (Baltimore). 2016 Aug;95(31):e4329. doi: 10.1097/MD.0000000000004329.

18.

Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.

Rao GG, Ly NS, Bulitta JB, Soon RL, San Roman MD, Holden PN, Landersdorfer CB, Nation RL, Li J, Forrest A, Tsuji BT.

J Antimicrob Chemother. 2016 Nov;71(11):3148-3156. Epub 2016 Aug 3.

PMID:
27494922
19.

Pseudomonas aeruginosa in premise plumbing of large buildings.

Bédard E, Prévost M, Déziel E.

Microbiologyopen. 2016 Dec;5(6):937-956. doi: 10.1002/mbo3.391. Epub 2016 Jun 28. Review.

20.

Inhaled Antibiotics for Gram-Negative Respiratory Infections.

Wenzler E, Fraidenburg DR, Scardina T, Danziger LH.

Clin Microbiol Rev. 2016 Jul;29(3):581-632. doi: 10.1128/CMR.00101-15. Review.

PMID:
27226088

Supplemental Content

Support Center